LivaNova (LIVN) Income from Continuing Operations (2014 - 2026)
LivaNova (LIVN) posted Income from Continuing Operations of 23145000.0 for Q1 2026, down 25.14% sequentially from 30916000.0 in Q4 2025, and up 107.07% YoY from 11177301.32 in Q1 2025.
LivaNova (LIVN) Income from Continuing Operations (2014 - 2026) Analysis & Trends
LivaNova has reported Income from Continuing Operations for 13 years, with the latest figure at 23145000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 107.07% year-over-year to 23145000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 108027000.0 (up 148.63% YoY) and the FY2025 annual result came in at 242420000.0, down 483.26% from the prior year.
- Income from Continuing Operations retreated to 23145000.0 in Q1 2026 per LIVN's latest filing, from 30916000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 55891000.0 in Q4 2024 and troughed at 327302000.0 in Q1 2025.
- A 5-year average of 13209764.71 and a median of 16356000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 1283.09% in 2024, then slumped 680.83% in 2025.
- Over 5 years, Income from Continuing Operations stood at 1690000.0 in 2022, then jumped by 867.81% to 16356000.0 in 2023, then jumped by 241.72% to 55891000.0 in 2024, then sank by 44.69% to 30916000.0 in 2025, then decreased by 25.14% to 23145000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 23145000.0, 30916000.0, and 26797000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 201.00 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 108.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.68 Mn |
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Sep 30, 2021 | -43.42 Mn |